141 related articles for article (PubMed ID: 10589793)
21. RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults.
Elisei R; Romei C; Vorontsova T; Cosci B; Veremeychik V; Kuchinskaya E; Basolo F; Demidchik EP; Miccoli P; Pinchera A; Pacini F
J Clin Endocrinol Metab; 2001 Jul; 86(7):3211-6. PubMed ID: 11443191
[TBL] [Abstract][Full Text] [Related]
22. RET activation and clinicopathologic features in poorly differentiated thyroid tumors.
Santoro M; Papotti M; Chiappetta G; Garcia-Rostan G; Volante M; Johnson C; Camp RL; Pentimalli F; Monaco C; Herrero A; Carcangiu ML; Fusco A; Tallini G
J Clin Endocrinol Metab; 2002 Jan; 87(1):370-9. PubMed ID: 11788678
[TBL] [Abstract][Full Text] [Related]
23. Detection of a novel type of RET rearrangement (PTC5) in thyroid carcinomas after Chernobyl and analysis of the involved RET-fused gene RFG5.
Klugbauer S; Demidchik EP; Lengfelder E; Rabes HM
Cancer Res; 1998 Jan; 58(2):198-203. PubMed ID: 9443391
[TBL] [Abstract][Full Text] [Related]
24. Papillary thyroid carcinoma oncogene (RET/PTC) alters the nuclear envelope and chromatin structure.
Fischer AH; Bond JA; Taysavang P; Battles OE; Wynford-Thomas D
Am J Pathol; 1998 Nov; 153(5):1443-50. PubMed ID: 9811335
[TBL] [Abstract][Full Text] [Related]
25. High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant.
Thomas GA; Bunnell H; Cook HA; Williams ED; Nerovnya A; Cherstvoy ED; Tronko ND; Bogdanova TI; Chiappetta G; Viglietto G; Pentimalli F; Salvatore G; Fusco A; Santoro M; Vecchio G
J Clin Endocrinol Metab; 1999 Nov; 84(11):4232-8. PubMed ID: 10566678
[TBL] [Abstract][Full Text] [Related]
26. Pattern of radiation-induced RET and NTRK1 rearrangements in 191 post-chernobyl papillary thyroid carcinomas: biological, phenotypic, and clinical implications.
Rabes HM; Demidchik EP; Sidorow JD; Lengfelder E; Beimfohr C; Hoelzel D; Klugbauer S
Clin Cancer Res; 2000 Mar; 6(3):1093-103. PubMed ID: 10741739
[TBL] [Abstract][Full Text] [Related]
27. High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation.
Bounacer A; Wicker R; Caillou B; Cailleux AF; Sarasin A; Schlumberger M; Suárez HG
Oncogene; 1997 Sep; 15(11):1263-73. PubMed ID: 9315093
[TBL] [Abstract][Full Text] [Related]
28. Breakpoint characterization of the ret/PTC oncogene in human papillary thyroid carcinoma.
Smanik PA; Furminger TL; Mazzaferri EL; Jhiang SM
Hum Mol Genet; 1995 Dec; 4(12):2313-8. PubMed ID: 8634704
[TBL] [Abstract][Full Text] [Related]
29. The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids.
Powell DJ; Russell J; Nibu K; Li G; Rhee E; Liao M; Goldstein M; Keane WM; Santoro M; Fusco A; Rothstein JL
Cancer Res; 1998 Dec; 58(23):5523-8. PubMed ID: 9850089
[TBL] [Abstract][Full Text] [Related]
30. [Rearrangement of the RET gene in papillary thyroid carcinoma].
Wiench M; Włoch J; Oczko M; Gubała E; Jarzab B
Wiad Lek; 2001; 54 Suppl 1():64-71. PubMed ID: 12182064
[TBL] [Abstract][Full Text] [Related]
31. Hyalinizing trabecular tumors of the thyroid: a variant of papillary carcinoma?
Lloyd RV
Adv Anat Pathol; 2002 Jan; 9(1):7-11. PubMed ID: 11756755
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis of papillary thyroid carcinoma is facilitated by using an RT-PCR approach on laser-microdissected archival material to detect RET oncogene activation.
Lahr G; Stich M; Schütze K; Blümel P; Pösl H; Nathrath WB
Pathobiology; 2000; 68(4-5):218-26. PubMed ID: 11279350
[TBL] [Abstract][Full Text] [Related]
33. Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas.
Lanzi C; Borrello MG; Bongarzone I; Migliazza A; Fusco A; Grieco M; Santoro M; Gambetta RA; Zunino F; Della Porta G
Oncogene; 1992 Nov; 7(11):2189-94. PubMed ID: 1437145
[TBL] [Abstract][Full Text] [Related]
34. Detection of RET oncogene activation in human papillary thyroid carcinomas by in situ hybridisation.
Fabien N; Paulin C; Santoro M; Berger N; Grieco M; Galvain D; Barbier Y; Dubois PM; Fusco A
Br J Cancer; 1992 Dec; 66(6):1094-8. PubMed ID: 1457350
[TBL] [Abstract][Full Text] [Related]
35. The ret/PTC1 rearrangement is a common feature of Chernobyl-associated papillary thyroid carcinomas from Belarus.
Pisarchik AV; Ermak G; Fomicheva V; Kartel NA; Figge J
Thyroid; 1998 Feb; 8(2):133-9. PubMed ID: 9510121
[TBL] [Abstract][Full Text] [Related]
36. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma.
Melillo RM; Cirafici AM; De Falco V; Bellantoni M; Chiappetta G; Fusco A; Carlomagno F; Picascia A; Tramontano D; Tallini G; Santoro M
Am J Pathol; 2004 Aug; 165(2):511-21. PubMed ID: 15277225
[TBL] [Abstract][Full Text] [Related]
37. Rearrangements of RET and NTRK1 tyrosine kinase receptors in papillary thyroid carcinomas.
Pierotti MA; Vigneri P; Bongarzone I
Recent Results Cancer Res; 1998; 154():237-47. PubMed ID: 10027004
[TBL] [Abstract][Full Text] [Related]
38. A ret transgenic mouse model of thyroid carcinogenesis.
Capen C; Sagartz J
Lab Anim Sci; 1998 Dec; 48(6):580-3. PubMed ID: 10090080
[No Abstract] [Full Text] [Related]
39. Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma.
Santoro M; Dathan NA; Berlingieri MT; Bongarzone I; Paulin C; Grieco M; Pierotti MA; Vecchio G; Fusco A
Oncogene; 1994 Feb; 9(2):509-16. PubMed ID: 8290261
[TBL] [Abstract][Full Text] [Related]
40. RET/PTC and RET tyrosine kinase expression in adult papillary thyroid carcinomas.
Learoyd DL; Messina M; Zedenius J; Guinea AI; Delbridge LW; Robinson BG
J Clin Endocrinol Metab; 1998 Oct; 83(10):3631-5. PubMed ID: 9768676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
